Although many pharmacists are divided when it comes to their job satisfaction, most of them are happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.
All News
Advertisement
A study sought to determine how HIV avoids the antiviral protein, zinc-finger antiviral protein.
Advertisement
Patients with HIV who are diagnosed with chronic kidney disease have a higher burden of serious clinical events.
Top news of the day from across the health care landscape.
A study used sequence-based methods to identify specific virus characteristics that may help determine efficacy of antibody therapies in HIV.
Research has been conducted to produce a vaccination that gives patients long-lasting protection from influenza.
Advertisement
An analysis of efficacy and safety outcomes in patients receiving perampanel as first adjunctive antiepileptic drug found that almost half of the patients were seizure-free.
A recent study showed that effective lifestyle behavioral changes for patients with chronic kidney disease frequently involved education, goal setting, feedback, monitoring, and social support.
Jelly of the Month might not have impressed Clark Griswold, but we're sure there's a pharmacist on your gift list that would appreciate one of these items.
Researchers used an epidermal growth factor (EGF)-conjugated anthrax toxin that, after targeting EGFR, was internalized and triggered apoptosis in exposed bladder cancer cells.
Top news of the day from across the health care landscape.
Approximately 2 out of 6 study participants tested positive after vaping cannabis that contained 0.39% THC using urine testing methods.
With this approval, enzalutamide is the first and only oral treatment approved by the FDA in 3 distinct types of advanced prostate cancer.
The CDC reported progress with the current status of the 3 strategies within the national initiative, Ending the HIV Epidemic: A Plan for America.
The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.
A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.
What is causing a patient’s memory loss?
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Clears First Comprehensive At-Home Cervical Cancer Screening Tool
2
CDC Suspends Dozens of Diagnostic Tests Amid Agency Downsizing, Raising Alarms for Pharmacists and Public Health
3
Quadruplet Therapy With Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma
4
Q&A: COVID-19–Associated Immune Response Linked to Increased Risk of Kidney Failure
5